Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis.
Int Arch Allergy Immunol. 2020;181(8):613-617. doi: 10.1159/000508559. Epub 2020 Jun 22.
Int Arch Allergy Immunol. 2020.
PMID: 32570256
Clinical Trial.